HER2 Antibody Market 2027 Type, Distribution Channel | The Insight Partners

HER2 Antibody Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ( Trastuzumab, Lapatinib, Ado-trastuzumab emtansine, Pertuzumab, Everolimus ); Distribution Channel ( Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels )

Report Code: TIPRE00010957 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

HER2 is a tyrosine kinase receptor which belongs to the ErbB/HER family. Additionally, the molecule includes ErbB3/HER3, epidermal growth factor receptor, and ErbB4/HER4. These receptors are extensively used for the treatment of cancer.

MARKET DYNAMICS

The HER2 Antibody Market growth is prominently attributed to increasing prevalence of breast cancer and extensively growing research and development activities. Additionally, increasing number of startup companies and technology collaborations are also projected to drive the market growth. However, higher treatment cost is anticipated to hamper the growth of the market during the forecast period.

MARKET SCOPE

The "HER2 Antibody Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of HER2 Antibody Market with detailed market segmentation by application and distribution channel. The HER2 Antibody Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in HER2 Antibody Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The HER2 Antibody Market is segmented on the basis of type and distribution channel. Based on type, the market is segmented as Trastuzumab, Lapatinib, Ado-trastuzumab emtansine, Pertuzumab, and Everolimus. On the basis of distribution channel, the market is categorized as hospital pharmacy, online pharmacy, retail pharmacy, and other distribution channels.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the HER2 Antibody Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The HER2 Antibody Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting HER2 Antibody Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the HER2 Antibody Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the HER2 Antibody Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from HER2 Antibody Market are anticipated to have lucrative growth opportunities in the future with the rising demand for radiotherapy devices in the global market. Below mentioned is the list of few companies engaged in the HER2 Antibody Market.

The report also includes the profiles of key players in HER2 Antibody Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •  Novartis AG
  •  Genentech Inc.
  •  Abnova Corporation
  •  Pfizer, Inc.
  •  InvivoGen
  •  Biocon Limited
  •  Bio-Techne
  •  Celltrion, Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 HER2 Antibody Market - By Type
1.3.2 HER2 Antibody Market - By Distribution Channel
1.3.3 HER2 Antibody Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HER2 ANTIBODY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HER2 ANTIBODY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HER2 ANTIBODY MARKET - GLOBAL MARKET ANALYSIS
6.1. HER2 ANTIBODY - GLOBAL MARKET OVERVIEW
6.2. HER2 ANTIBODY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HER2 ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRASTUZUMAB
7.3.1. Overview
7.3.2. Trastuzumab Market Forecast and Analysis
7.4. LAPATINIB
7.4.1. Overview
7.4.2. Lapatinib Market Forecast and Analysis
7.5. ADO-TRASTUZUMAB EMTANSINE
7.5.1. Overview
7.5.2. Ado-trastuzumab emtansine Market Forecast and Analysis
7.6. PERTUZUMAB
7.6.1. Overview
7.6.2. Pertuzumab Market Forecast and Analysis
7.7. EVEROLIMUS
7.7.1. Overview
7.7.2. Everolimus Market Forecast and Analysis
8. HER2 ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACY
8.3.1. Overview
8.3.2. Hospital Pharmacy Market Forecast and Analysis
8.4. ONLINE PHARMACY
8.4.1. Overview
8.4.2. Online Pharmacy Market Forecast and Analysis
8.5. RETAIL PHARMACY
8.5.1. Overview
8.5.2. Retail Pharmacy Market Forecast and Analysis
8.6. OTHER DISTRIBUTION CHANNELS
8.6.1. Overview
8.6.2. Other Distribution Channels Market Forecast and Analysis
9. HER2 ANTIBODY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America HER2 Antibody Market Overview
9.1.2 North America HER2 Antibody Market Forecasts and Analysis
9.1.3 North America HER2 Antibody Market Forecasts and Analysis - By Type
9.1.4 North America HER2 Antibody Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America HER2 Antibody Market Forecasts and Analysis - By Countries
9.1.5.1 United States HER2 Antibody Market
9.1.5.1.1 United States HER2 Antibody Market by Type
9.1.5.1.2 United States HER2 Antibody Market by Distribution Channel
9.1.5.2 Canada HER2 Antibody Market
9.1.5.2.1 Canada HER2 Antibody Market by Type
9.1.5.2.2 Canada HER2 Antibody Market by Distribution Channel
9.1.5.3 Mexico HER2 Antibody Market
9.1.5.3.1 Mexico HER2 Antibody Market by Type
9.1.5.3.2 Mexico HER2 Antibody Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe HER2 Antibody Market Overview
9.2.2 Europe HER2 Antibody Market Forecasts and Analysis
9.2.3 Europe HER2 Antibody Market Forecasts and Analysis - By Type
9.2.4 Europe HER2 Antibody Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe HER2 Antibody Market Forecasts and Analysis - By Countries
9.2.5.1 Germany HER2 Antibody Market
9.2.5.1.1 Germany HER2 Antibody Market by Type
9.2.5.1.2 Germany HER2 Antibody Market by Distribution Channel
9.2.5.2 France HER2 Antibody Market
9.2.5.2.1 France HER2 Antibody Market by Type
9.2.5.2.2 France HER2 Antibody Market by Distribution Channel
9.2.5.3 Italy HER2 Antibody Market
9.2.5.3.1 Italy HER2 Antibody Market by Type
9.2.5.3.2 Italy HER2 Antibody Market by Distribution Channel
9.2.5.4 Spain HER2 Antibody Market
9.2.5.4.1 Spain HER2 Antibody Market by Type
9.2.5.4.2 Spain HER2 Antibody Market by Distribution Channel
9.2.5.5 United Kingdom HER2 Antibody Market
9.2.5.5.1 United Kingdom HER2 Antibody Market by Type
9.2.5.5.2 United Kingdom HER2 Antibody Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific HER2 Antibody Market Overview
9.3.2 Asia-Pacific HER2 Antibody Market Forecasts and Analysis
9.3.3 Asia-Pacific HER2 Antibody Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific HER2 Antibody Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific HER2 Antibody Market Forecasts and Analysis - By Countries
9.3.5.1 Australia HER2 Antibody Market
9.3.5.1.1 Australia HER2 Antibody Market by Type
9.3.5.1.2 Australia HER2 Antibody Market by Distribution Channel
9.3.5.2 China HER2 Antibody Market
9.3.5.2.1 China HER2 Antibody Market by Type
9.3.5.2.2 China HER2 Antibody Market by Distribution Channel
9.3.5.3 India HER2 Antibody Market
9.3.5.3.1 India HER2 Antibody Market by Type
9.3.5.3.2 India HER2 Antibody Market by Distribution Channel
9.3.5.4 Japan HER2 Antibody Market
9.3.5.4.1 Japan HER2 Antibody Market by Type
9.3.5.4.2 Japan HER2 Antibody Market by Distribution Channel
9.3.5.5 South Korea HER2 Antibody Market
9.3.5.5.1 South Korea HER2 Antibody Market by Type
9.3.5.5.2 South Korea HER2 Antibody Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa HER2 Antibody Market Overview
9.4.2 Middle East and Africa HER2 Antibody Market Forecasts and Analysis
9.4.3 Middle East and Africa HER2 Antibody Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa HER2 Antibody Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa HER2 Antibody Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa HER2 Antibody Market
9.4.5.1.1 South Africa HER2 Antibody Market by Type
9.4.5.1.2 South Africa HER2 Antibody Market by Distribution Channel
9.4.5.2 Saudi Arabia HER2 Antibody Market
9.4.5.2.1 Saudi Arabia HER2 Antibody Market by Type
9.4.5.2.2 Saudi Arabia HER2 Antibody Market by Distribution Channel
9.4.5.3 U.A.E HER2 Antibody Market
9.4.5.3.1 U.A.E HER2 Antibody Market by Type
9.4.5.3.2 U.A.E HER2 Antibody Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America HER2 Antibody Market Overview
9.5.2 South and Central America HER2 Antibody Market Forecasts and Analysis
9.5.3 South and Central America HER2 Antibody Market Forecasts and Analysis - By Type
9.5.4 South and Central America HER2 Antibody Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America HER2 Antibody Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil HER2 Antibody Market
9.5.5.1.1 Brazil HER2 Antibody Market by Type
9.5.5.1.2 Brazil HER2 Antibody Market by Distribution Channel
9.5.5.2 Argentina HER2 Antibody Market
9.5.5.2.1 Argentina HER2 Antibody Market by Type
9.5.5.2.2 Argentina HER2 Antibody Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HER2 ANTIBODY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HER2 ANTIBODY MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENENTECH INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABNOVA CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. INVIVOGEN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOCON LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIO-TECHNE
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CELLTRION, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Genentech Inc.
3. Abnova Corporation
4. Pfizer, Inc.
5. InvivoGen
6. Biocon Limited
7. Bio-Techne
8. Celltrion, Inc.
TIPRE00010957
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking